Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsRobyn M. Emanuel, Ruben A. Mesa, Norman Maldonado et al.|Journal of Clinical Oncology|2012Cited by 461
The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patientsPhilipp S. Goerttler, Heike L. Pahl, Cordula Steimle et al.|Blood|2005Cited by 97
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L. Geyer, Peihong Zhang, Heidi Kosiorek et al.|Haematologica|2016Cited by 73
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly L. Geyer, Jan Samuelsson, Robyn M. Scherber et al.|Journal of Clinical Oncology|2015Cited by 65
JAK2-negative ET patients do not display constitutively active JAK/STAT signalingSven Schwemmers, Heike L. Pahl, Britta Will et al.|Experimental Hematology|2007Cited by 35